The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
As part of The Wistar Institute’s Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
About 1,100 people are diagnosed with melanoma skin cancer each year in Ireland, and Cork native Peter has spoken out to warn ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...
Melanoma is deadlier for Black individuals due to late diagnoses and hidden symptoms. Understanding the risks can save lives.
Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.
Lake Street initiated coverage of Sensus Healthcare (SRTS) with a Buy rating and $18 price target Sensus’ superficial radiation therapy is a ...
Dr. Christine Kannler gives free skin cancer screenings at local fire stations across the Commonwealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback